Suchergebnisse - "Bossi, Paolo"

PubPharm (531)

1

Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Wardill, H. | Bossi, P. | Sonis, S.

2

The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Hermsen, M. | Bossi, P. | Capper, D. | +12

3

Correction : Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

enthalten in: BMC cancer | 2024

von Cirillo, A. | Marinelli, D. | Romeo, U. | +14

ErratumFor: BMC Cancer. 2024 Apr 8;24(1):430. - PMID 38589857

4

Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

enthalten in: BMC cancer | 2024

von Cirillo, A. | Marinelli, D. | Romeo, U. | +14

5

Bridging gaps in cancer cachexia Care : Current insights and future perspectives

enthalten in: Cancer treatment reviews | 2024

von Bianchini, C. | Bonomo, P. | Bossi, P. | +2

6

International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study

enthalten in: bioRxiv.org | 2024

von Moreno, A. | Watson, E. | Humbert-Vidan, L. | +66

7

International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers

enthalten in: Head & neck | 2024

von Liem, X. | de Baère, T. | Vivar, O. | +15

8

International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw : An Inter-Disciplinary Modified Delphi Study

enthalten in: medRxiv : the preprint server for health sciences | 2024

von International ORAL Consortium | Moreno, A. | Watson, E. | +67

9

Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma : a retrospective analysis

enthalten in: BMC cancer | 2024

von Cirillo, A. | Marinelli, D. | Romeo, U. | +14

ErratumIn: BMC Cancer. 2024 Apr 17;24(1):487. - PMID 38632499

10

Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

enthalten in: BMC cancer | 2024

von Cirillo, A. | Marinelli, D. | Romeo, U. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]